AN
Nguyen, Aude
Affiliation entities
Research groups
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Epidémiologie, facteurs de risque et outcomes des bactériémies pendant la période d’aplasie chez les receveurs de greffe de cellules souches hématopoïétiques | 2025 | 13 | 3 | ||||
Increase in PVC-BSI during the second COVID-19 pandemic year : analysis of catheter and patient characteristics | Antimicrobial resistance and infection control | 2024 | 16 | 21 | |||
Potent in-vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates | Clinical microbiology and infection | 2024 | 20 | 0 | |||
Impact of intermittent versus continuous infusions on central line-associated bloodstream infection risk in haemato-oncology patients : a quasi-experimental study | Journal of hospital infection | 2024 | 11 | 13 | |||
Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis | Transplant infectious disease | 2024 | 14 | 16 | |||
Controlling the hospital aquatic reservoir of multidrug-resistant organisms : a cross-sectional study followed by a nested randomized trial of sink decontamination | Clinical microbiology and infection | 2024 | 47 | 21 | |||
Postpartum septic arthritis of pubic symphysis due to Sneathia sanguinegens, Sneathia vaginalis, and Mageeibacillus indolicus : Contribution of clinicalmetagenomics | New microbes and new infections | 2023 | 93 | 26 | |||
Increased Peripheral Venous Catheter Bloodstream Infections during COVID-19 Pandemic, Switzerland | Emerging infectious diseases | 2023 | 71 | 38 | |||
Hepatitis C treatment program in Maputo, Mozambique, the challenge of genotypes and key populations : A 5-year retrospective analysis of routine programmatic data | Health science reports | 2023 | 50 | 7 | |||
Epidemiological characteristics and real-world treatment outcomes of hepatitis C among HIV/HCV co-infected patients in Myanmar : A prospective cohort study | Health science reports | 2023 | 44 | 14 | |||
Prevention of mother-to-child transmission of hepatitis B virus in antenatal care and maternity services, Mozambique | Bulletin of the World Health Organization | 2022 | 34 | 7 | |||
Letermovir for cytomegalovirus primary prophylaxis in a multiple abdominal/small bowel transplant recipient | Clinical transplantation | 2022 | 201 | 0 | |||
Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar | BMJ global health | 2021 | 36 | 9 | |||
Fièvre d’origine indéterminée : cheval, zèbre ou licorne ? | Revue médicale suisse | 2021 | 31 | 21 | |||
HCV genetic diversity can be used to infer infection recency and time since infection | Viruses | 2020 | 156 | 56 |